Boehringer Ingelheim and CDR-Life to develop Antibody Fragment-based Therapeutics for Geographic… EP News Bureau May 15, 2020 The collaboration with CDR-Life is the second strategic partnership within a year for Boehringer Ingelheim in retinal diseases,…
